ISD Immunotech is developing STING modulators to treat severe Systemic lupus erythematosus (SLE) or Lupus by targeting the STING pathway. SLE is a complex and devastating autoimmune disease with few to no good options for treatment especially for the most severe patients. STimulator of INterferon Gene (STING) is a target that controls innate immunity and has shown to be overactive in severe SLE making it an exciting new therapeutic target for SLE.
| Website | http://www.isd-immunotech.com |
| Employees | 1 (0 on RocketReach) |
| Founded | 2013 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+6 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Lupus Treatment, Autoimmune Therapies, Immunology Research, Targeted Therapy, Therapeutic Drug Development, Drug Discovery, Pharmaceutical Research, Immune System, Inflammation, Biotechnology, Precision Medicine, Treatment Options, Clinical Trials, Molecular Biology |
Looking for a particular ISD-Immunotech employee's phone or email?
ISD-Immunotech Questions
Related Companies
G2Crowd Trusted
300K+
Plugin Users
